Skip to content
NBlaz – Lifestyle
Author:
ADC Therapeutics SA
ADC Therapeutics Announces New Employee Inducement Grant
November 2, 2026
ADC Therapeutics to Announce Third Quarter 2026 Financial Results on November 9, 2026
November 2, 2026
ADC Therapeutics Announces ZYNLONTA® Updates in Japan
October 29, 2026
ADC Therapeutics Announces Comprehensive Strategic Financial Restructuring Marking Key Capital Structure Improvements
October 8, 2026
ADC Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
September 3, 2026
ADC Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Updates
August 13, 2026
ADC Therapeutics to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026
August 6, 2026
ADC Therapeutics Announces New Employee Inducement Grant
July 1, 2026
ADC Therapeutics Announces Completion of Enrollment in LOTIS-7 Phase 1b ZYNLONTA® Combination Trial
June 30, 2026
ADC Therapeutics Announces Strategic Reorganization to Support ZYNLONTA® Growth Opportunities and Regulatory Priorities
June 24, 2026
1
2
Next Page
→